| Nombre del producto |
N6-2'-O-Dibutyryl-adenosine 3',5'-cyclophosphate sodium salt monohydrate |
| Nombre en inglés |
N6-2'-O-Dibutyryl-adenosine 3',5'-cyclophosphate sodium salt monohydrate; Poly I-poly C; Bucladesine sodium salt; Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate)-2'-butanoate, monosodium salt; Bucladesine sodium; DT 5621 sodium salt; Dibutyl cAMP sodium salt; Dibutyl cyclic AMP sodium; Dibutyl cyclic AMP sodium salt; Monosodium dibutyryl cyclic AMP; Sodium dibutyryl 3',5'-cyclic AMP; Sodium dibutyryl cAMP; Sodium dibutyryl cyclic adenosine-3',5'-monophosphate; Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate, monosodium salt; Butyramide, N-(9-beta-D-ribofuranosyl-9H-purin-6-yl)-, cyclic hydrogen phosphate, butyrate (ester), monosodium salt; sodium (4aR,6R,7R,7aR)-6-[6-(butanoylamino)-9H-purin-9-yl]-7-(butanoyloxy)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide; n-6,o-2'-dibutyryladenosine cyclic 3',5'-monophosphate sodium salt |
| Fórmula molecular |
C18H23N5NaO8P |
| Peso Molecular |
491.3675 |
| InChI |
InChI=1/C18H24N5O8P.Na/c1-3-5-11(24)22-16-13-17(20-8-19-16)23(9-21-13)18-15(30-12(25)6-4-2)14-10(29-18)7-28-32(26,27)31-14;/h8-10,14-15,18H,3-7H2,1-2H3,(H,26,27)(H,19,20,22,24);/q;+1/p-1/t10-,14-,15-,18-;/m1./s1 |
| Número de registro CAS |
16980-89-5 |
| EINECS |
241-059-4 |
| Estructura Molecular |
|
| Símbolos de Peligro |
|
| Códigos de Riesgos |
|
| Descripción de Seguridad |
|
|
